CohBar (CWBR) Competitors $0.54 0.00 (0.00%) (As of 12/20/2024 04:04 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends CWBR vs. AIMD, EDSA, ONVO, CNSP, SYRS, GTBP, HOTH, IMCC, CANF, and ELABShould you be buying CohBar stock or one of its competitors? The main competitors of CohBar include Ainos (AIMD), Edesa Biotech (EDSA), Organovo (ONVO), CNS Pharmaceuticals (CNSP), Syros Pharmaceuticals (SYRS), GT Biopharma (GTBP), Hoth Therapeutics (HOTH), IM Cannabis (IMCC), Can-Fite BioPharma (CANF), and Elevai Labs (ELAB). These companies are all part of the "pharmaceutical products" industry. CohBar vs. Ainos Edesa Biotech Organovo CNS Pharmaceuticals Syros Pharmaceuticals GT Biopharma Hoth Therapeutics IM Cannabis Can-Fite BioPharma Elevai Labs Ainos (NASDAQ:AIMD) and CohBar (NASDAQ:CWBR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability. Does the media refer more to AIMD or CWBR? In the previous week, Ainos' average media sentiment score of 0.00 equaled CohBar'saverage media sentiment score. Company Overall Sentiment Ainos Neutral CohBar Neutral Which has higher earnings and valuation, AIMD or CWBR? CohBar has lower revenue, but higher earnings than Ainos. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAinos$40.63K153.64-$13.77MN/AN/ACohBarN/AN/A-$12.18MN/AN/A Does the MarketBeat Community believe in AIMD or CWBR? CohBar received 18 more outperform votes than Ainos when rated by MarketBeat users. CompanyUnderperformOutperformAinosN/AN/ACohBarOutperform Votes1872.00% Underperform Votes728.00% Do institutionals & insiders have more ownership in AIMD or CWBR? 2.5% of CohBar shares are held by institutional investors. 10.4% of Ainos shares are held by insiders. Comparatively, 6.5% of CohBar shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk & volatility, AIMD or CWBR? Ainos has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, CohBar has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Is AIMD or CWBR more profitable? CohBar has a net margin of 0.00% compared to Ainos' net margin of -15,348.14%. CohBar's return on equity of 0.00% beat Ainos' return on equity.Company Net Margins Return on Equity Return on Assets Ainos-15,348.14% -75.16% -50.22% CohBar N/A N/A N/A SummaryCohBar beats Ainos on 6 of the 9 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get CohBar News Delivered to You Automatically Sign up to receive the latest news and ratings for CWBR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CWBR vs. The Competition Export to ExcelMetricCohBarPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.57M$6.57B$5.14B$9.08BDividend YieldN/A2.99%5.09%4.23%P/E RatioN/A10.5990.0517.18Price / SalesN/A196.061,116.25117.06Price / CashN/A57.1643.1037.85Price / Book0.105.094.784.78Net Income-$12.18M$151.83M$120.31M$225.60M7 Day PerformanceN/A-2.14%-1.92%-1.23%1 Month Performance8.00%-4.56%13.65%0.46%1 Year Performance-28.01%8.87%28.34%15.24% CohBar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CWBRCohBarN/A$0.54flatN/A-28.0%$1.57MN/A0.0010High Trading VolumeAIMDAinosN/A$0.45+2.5%N/A-80.1%$6.24M$120,000.000.0046Gap DownEDSAEdesa Biotech3.5595 of 5 stars$1.90-1.9%$21.00+1,005.3%-64.1%$6.18MN/A-1.0020Earnings ReportPositive NewsGap DownHigh Trading VolumeONVOOrganovoN/A$0.39-3.6%N/A-67.6%$5.99M$110,000.000.0020Analyst ForecastCNSPCNS Pharmaceuticals1.224 of 5 stars$0.10-0.6%$0.50+388.8%-99.8%$5.88MN/A0.005Gap DownSYRSSyros Pharmaceuticals4.2571 of 5 stars$0.21+2.9%$3.33+1,463.5%-96.5%$5.72M$9.94M-0.07120Gap UpGTBPGT Biopharma3.6544 of 5 stars$2.51-8.7%$11.00+338.2%-78.3%$5.61MN/A0.008Positive NewsGap UpHOTHHoth Therapeutics2.0095 of 5 stars$0.81+0.1%$3.50+331.6%-30.8%$5.60MN/A-0.614Gap UpIMCCIM Cannabis0.0474 of 5 stars$2.38-3.6%N/A+3.4%$5.31M$51.39M-0.72340Gap DownCANFCan-Fite BioPharma1.7922 of 5 stars$1.50-5.1%$14.00+833.4%-30.7%$5.31M$667,000.00-0.888ELABElevai Labs0.3441 of 5 stars$2.03-11.4%N/A-99.3%$5.25M$2.45M-0.0318News CoverageGap Down Related Companies and Tools Related Companies Ainos Alternatives Edesa Biotech Alternatives Organovo Alternatives CNS Pharmaceuticals Alternatives Syros Pharmaceuticals Alternatives GT Biopharma Alternatives Hoth Therapeutics Alternatives IM Cannabis Alternatives Can-Fite BioPharma Alternatives Elevai Labs Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CWBR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our Partners⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CohBar, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CohBar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
